Americans Should Buy Canadian Cannabis Companies

Canadian Licensed Producers (LPs) are identified as a more compelling investment than U.S. Multi-State Operators (MSOs) in the cannabis sector, citing LPs' stronger balance sheets, tangible book value, and global market access due to federal legality, which contribute to attractive enterprise value to EBITDA valuations despite recent rallies. Conversely, U.S. MSOs face significant risks from 280E tax liabilities and negative tangible equity. Investors are advised to prioritize fundamentally sound Canadian LPs, specifically mentioning Village Farms, Organigram, and Tilray Brands, while exercising caution with overvalued names like Canopy Growth, even after the sector's recent strong performance.

Analysis

The current investment landscape in the cannabis sector presents a notable divergence between Canadian Licensed Producers (LPs) and U.S. Multi-State Operators (MSOs), with Canadian LPs offering a more compelling risk/reward profile. This is attributed to their stronger balance sheets, positive tangible book value, and strategic advantages stemming from federal legality, which opens up global market opportunities. Despite a recent rally in their stock prices, select Canadian LPs, specifically Village Farms (VFF), Organigram (OGI), and Tilray Brands (TLRY), are highlighted as remaining undervalued on an enterprise value to EBITDA basis. In contrast, U.S. MSOs are burdened by significant structural risks, including punitive 280E tax liabilities and negative tangible equity, making them a comparatively less safe investment at present. The analysis suggests a fundamentals-driven approach, cautioning against overvalued names like Canopy Growth (CGC) and indicating that even after strong sector performance, selective exposure to fundamentally sound Canadian operators is the prudent strategy.

Key Decisions for Investors

• Investors should consider overweighting exposure to Canadian LPs versus U.S. MSOs, capitalizing on the former's superior balance sheet health and insulation from adverse U.S. 280E tax regulations.
• Focus capital on fundamentally sound Canadian LPs such as Village Farms (VFF), Organigram (OGI), and Tilray Brands (TLRY), which are identified as having attractive enterprise value to EBITDA valuations.
• Exercise caution or potentially underweight positions in Canopy Growth (CGC), as it is flagged for being overvalued relative to its fundamentals.
• For portfolios that have experienced significant recent gains in this sector, it may be prudent to trim positions to lock in profits while maintaining a core holding in the favored, fundamentally strong names.